Abstract:Cerebellofaciodental syndrome is characterized by facial dysmorphisms, intellectual disability, cerebellar hypoplasia, and dental anomalies. It is an autosomal‐recessive condition described in 2015 caused by pathogenic variants in BRF1. Here, we report a Brazilian patient who faced a diagnostic challenge beginning at 11 months of age. Fortunately, whole‐exome sequencing (WES) was performed, detecting the BRF1 variants NM_001519.3:c.1649delG:p.(Gly550Alafs*36) and c.421C>T:p.(Arg141Cys) in compound heterozygosi… Show more
“…Additionally, BRF1 mutations have been shown to be causative for cerebellofaciadental syndrome (34,35,61). Some patients with RNA pol III-related mutations, but not all, show bone-related phenotypes (34)(35)(36)(37)(38). The considerable heterogeneity of these syndromes has been suggested to be related to differential changes in RNA pol III-dependent transcription (55).…”
Section: Discussionmentioning
confidence: 99%
“…This includes POLR3related hypomyelinating leukodystrophies (54-56), Wiedemann-Rautenstrauch syndrome, a neonatal progeroid syndrome (57-60) and Cerebellar hypoplasia with endosteal sclerosis (37,38). Additionally, BRF1 mutations have been shown to be causative for cerebellofaciadental syndrome (34,35,61). Some patients with RNA pol III-related mutations, but not all, show bone-related phenotypes (34)(35)(36)(37)(38).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, RNA pol III-dependent transcription may play a role in Cerebellofaciodental syndrome which is associated with mutations in the RNA pol III-specific transcription factor, BRF1. This syndrome is characterized by a neurodevelopmental phenotype as well as changes in the facial and dental structure and delayed bone age (34)(35)(36) . Additionally, bone phenotypes have been described in a subgroup of patients with mutations in RNA pol III subunits (34)(35)(36)(37)(38).…”
Section: Introductionmentioning
confidence: 99%
“…This syndrome is characterized by a neurodevelopmental phenotype as well as changes in the facial and dental structure and delayed bone age (34)(35)(36) . Additionally, bone phenotypes have been described in a subgroup of patients with mutations in RNA pol III subunits (34)(35)(36)(37)(38).…”
Maf1, a key repressor of RNA polymerase III-mediated transcription, has been shown to promote mesoderm formation in vitro. Here, we show, for the first time, that Maf1 plays a critical role in the regulation of osteoblast differentiation and bone mass. A high bone mass phenotype was noted in mice with global deletion of Maf1 (Maf1-/- mice), as well as paradoxically, in mice that overexpressed MAF1 in cells of the osteoblast lineage (Prx1-Cre;LSL-Maf1 mice). Osteoblasts isolated from Maf1-/- mice showed reduced osteoblastogenesis ex vivo. Prx1-Cre;LSL-MAF1 mice showed enhanced osteoblastogenesis concordant with their high bone mass phenotype. Thus, the high bone mass phenotype in Maf1-/- mice is likely due to the confounding effects of the global absence of Maf1 in Maf1-/- mice. Expectedly, MAF1 overexpression promoted osteoblast differentiation and shRNA-mediated Maf1 downregulation inhibited differentiation of ST2 cells, overall indicating Maf1 enhances osteoblast formation. We also found that, in contrast to MAF1 overexpression, other perturbations that repress RNA pol III transcription, including Brf1 knockdown and the chemical inhibition of RNA pol III by ML-60218, inhibited osteoblast differentiation. All perturbations that decrease RNA pol III transcription, however, enhanced adipogenesis in ST2 cell cultures. RNA-seq was used to determine the basis for these opposing actions on osteoblast differentiation. The modalities used to alter RNA pol III transcription resulted in distinct changes gene expression, indicating that this transcription process is highly sensitive to perturbations and triggers diverse gene expression programs and phenotypic outcomes. Specifically, Maf1 induced genes in ST2 cells known to promote osteoblast differentiation. Furthermore, genes that are induced during osteoblast differentiation displayed codon bias. Together, these results reveal a novel role for Maf1 and RNA pol III-mediated transcription in osteoblast fate determination and differentiation and bone mass regulation.
“…Additionally, BRF1 mutations have been shown to be causative for cerebellofaciadental syndrome (34,35,61). Some patients with RNA pol III-related mutations, but not all, show bone-related phenotypes (34)(35)(36)(37)(38). The considerable heterogeneity of these syndromes has been suggested to be related to differential changes in RNA pol III-dependent transcription (55).…”
Section: Discussionmentioning
confidence: 99%
“…This includes POLR3related hypomyelinating leukodystrophies (54-56), Wiedemann-Rautenstrauch syndrome, a neonatal progeroid syndrome (57-60) and Cerebellar hypoplasia with endosteal sclerosis (37,38). Additionally, BRF1 mutations have been shown to be causative for cerebellofaciadental syndrome (34,35,61). Some patients with RNA pol III-related mutations, but not all, show bone-related phenotypes (34)(35)(36)(37)(38).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, RNA pol III-dependent transcription may play a role in Cerebellofaciodental syndrome which is associated with mutations in the RNA pol III-specific transcription factor, BRF1. This syndrome is characterized by a neurodevelopmental phenotype as well as changes in the facial and dental structure and delayed bone age (34)(35)(36) . Additionally, bone phenotypes have been described in a subgroup of patients with mutations in RNA pol III subunits (34)(35)(36)(37)(38).…”
Section: Introductionmentioning
confidence: 99%
“…This syndrome is characterized by a neurodevelopmental phenotype as well as changes in the facial and dental structure and delayed bone age (34)(35)(36) . Additionally, bone phenotypes have been described in a subgroup of patients with mutations in RNA pol III subunits (34)(35)(36)(37)(38).…”
Maf1, a key repressor of RNA polymerase III-mediated transcription, has been shown to promote mesoderm formation in vitro. Here, we show, for the first time, that Maf1 plays a critical role in the regulation of osteoblast differentiation and bone mass. A high bone mass phenotype was noted in mice with global deletion of Maf1 (Maf1-/- mice), as well as paradoxically, in mice that overexpressed MAF1 in cells of the osteoblast lineage (Prx1-Cre;LSL-Maf1 mice). Osteoblasts isolated from Maf1-/- mice showed reduced osteoblastogenesis ex vivo. Prx1-Cre;LSL-MAF1 mice showed enhanced osteoblastogenesis concordant with their high bone mass phenotype. Thus, the high bone mass phenotype in Maf1-/- mice is likely due to the confounding effects of the global absence of Maf1 in Maf1-/- mice. Expectedly, MAF1 overexpression promoted osteoblast differentiation and shRNA-mediated Maf1 downregulation inhibited differentiation of ST2 cells, overall indicating Maf1 enhances osteoblast formation. We also found that, in contrast to MAF1 overexpression, other perturbations that repress RNA pol III transcription, including Brf1 knockdown and the chemical inhibition of RNA pol III by ML-60218, inhibited osteoblast differentiation. All perturbations that decrease RNA pol III transcription, however, enhanced adipogenesis in ST2 cell cultures. RNA-seq was used to determine the basis for these opposing actions on osteoblast differentiation. The modalities used to alter RNA pol III transcription resulted in distinct changes gene expression, indicating that this transcription process is highly sensitive to perturbations and triggers diverse gene expression programs and phenotypic outcomes. Specifically, Maf1 induced genes in ST2 cells known to promote osteoblast differentiation. Furthermore, genes that are induced during osteoblast differentiation displayed codon bias. Together, these results reveal a novel role for Maf1 and RNA pol III-mediated transcription in osteoblast fate determination and differentiation and bone mass regulation.
“…The studies suggest a fusion between AOF and the dimensions of the foramen magnum that the sagittal dimensions and area of the foramen magnum were significantly smaller in skulls with occipitalization [13].Foramen magnum is an important landmark, which is closely associated with the brainstem and spinal cord [14]. AOF, reduced foramen magnum and basilar invagination which may compress the medulla-spinal cord transition and the spinal cord or brain stem [15].…”
In the routine anatomic measurement study on Asian dry skulls, a skull of atlantooccipital fusion with other multiple anatomic variations was observed. The entire right half of the atlas vertebra, including the anterior arch, anterior tubercle, posterior arch, and lateral masses, was fused entirely with the occipital bone, while the left fused partly.Besides the atlanto-occipital fusion, the target skull specimen also includes posterior arch defects of the atlas, metopic suture, wormian bones. So many anatomy variations rarely exist in one specimen. This paper aims to present detailed anatomic case reports and discuss related diseases in an anatomic and clinical study.
Cerebellofaciodental syndrome characterized with dysmorphic features, intellectual disability, and brain anomalies. Now its clinical spectrum expanded more manifestations including bilateral sensorineural hearing impairment and inner ear malformation. Here, we report a 14‐month‐old boy with global developmental delay and hearing disorder. Whole exome sequencing (WES) revealed the compound heterozygous variants [NM_001519.4: c.652 T > G (p.W218G); c.915 + 1G > T] in the BRF1 gene which inherited from his parents, respectively. The MRI results showed hypoplastic cerebellar vermis, enlarged cisterna magna, and prominent fourth ventricle, the rehabilitation therapy failed to improve the symptoms for our patient. Our finding expands the genetic spectrum of BRF1 variants, which indicates patients with the developmental delay caused by BRF1 variants require other treatments instead of rehabilitation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.